- Home
- VRDN vs PRG Comparison
VRDN vs PRG Comparison
Compare VRDN & PRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- PRG
- Stock Information
- Founded
- VRDN 2006
- PRG 2020
- Country
- VRDN United States
- PRG United States
- Employees
- VRDN N/A
- PRG N/A
- Industry
- VRDN Medical Specialities
- PRG Diversified Commercial Services
- Sector
- VRDN Health Care
- PRG Consumer Discretionary
- Exchange
- VRDN Nasdaq
- PRG Nasdaq
- Market Cap
- VRDN 1.3B
- PRG 1.2B
- IPO Year
- VRDN N/A
- PRG N/A
- Fundamental
- Price
- VRDN $14.34
- PRG $29.60
- Analyst Decision
- VRDN Strong Buy
- PRG Strong Buy
- Analyst Count
- VRDN 11
- PRG 5
- Target Price
- VRDN $38.50
- PRG $41.80
- AVG Volume (30 Days)
- VRDN 750.1K
- PRG 406.8K
- Earning Date
- VRDN 08-07-2025
- PRG 07-23-2025
- Dividend Yield
- VRDN N/A
- PRG 1.83%
- EPS Growth
- VRDN N/A
- PRG 99.08
- EPS
- VRDN N/A
- PRG 4.90
- Revenue
- VRDN $302,000.00
- PRG $2,505,714,000.00
- Revenue This Year
- VRDN N/A
- PRG $1.36
- Revenue Next Year
- VRDN $17,102.33
- PRG $4.29
- P/E Ratio
- VRDN N/A
- PRG $5.70
- Revenue Growth
- VRDN 4.86
- PRG 4.62
- 52 Week Low
- VRDN $9.90
- PRG $23.50
- 52 Week High
- VRDN $27.20
- PRG $50.28
- Technical
- Relative Strength Index (RSI)
- VRDN 50.32
- PRG 56.07
- Support Level
- VRDN $14.11
- PRG $28.87
- Resistance Level
- VRDN $16.05
- PRG $29.54
- Average True Range (ATR)
- VRDN 0.74
- PRG 0.86
- MACD
- VRDN -0.13
- PRG -0.01
- Stochastic Oscillator
- VRDN 20.18
- PRG 70.67
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
About PRG PROG Holdings Inc.
PROG Holdings Inc is a financial technology holding company that provides transparent and competitive payment options to consumers. The company has two reportable segments: Progressive Leasing, an in-store, app-based, and e-commerce point-of-sale lease-to-own solutions provider; and Vive Financial (Vive), an omnichannel provider of second-look revolving credit products. The majority of the revenue of the company is earned through the Progressive Leasing segment.